Cargando…
Impact of gadolinium‐ethoxybenzyl‐diethylenetriamine pentaacetic acid‐enhanced magnetic resonance imaging on the prognosis of hepatocellular carcinoma after surgery
BACKGROUND AND AIM: Gadolinium‐ethoxybenzyl‐diethylenetriamine pentaacetic acid (Gd‐EOB‐DTPA)‐enhanced magnetic resonance imaging (EOB‐MRI) has been recognized as a useful imaging technique to distinguish the biological behavior of hepatocellular carcinoma (HCC). METHODS: We analyzed 217 hepatectomy...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wiley Publishing Asia Pty Ltd
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7812518/ https://www.ncbi.nlm.nih.gov/pubmed/33490612 http://dx.doi.org/10.1002/jgh3.12444 |
_version_ | 1783637685748891648 |
---|---|
author | Shimada, Shingo Kamiyama, Toshiya Kakisaka, Tatsuhiko Orimo, Tatsuya Nagatsu, Akihisa Asahi, Yoh Sakamoto, Yuzuru Abo, Daisuke Kamachi, Hirofumi Taketomi, Akinobu |
author_facet | Shimada, Shingo Kamiyama, Toshiya Kakisaka, Tatsuhiko Orimo, Tatsuya Nagatsu, Akihisa Asahi, Yoh Sakamoto, Yuzuru Abo, Daisuke Kamachi, Hirofumi Taketomi, Akinobu |
author_sort | Shimada, Shingo |
collection | PubMed |
description | BACKGROUND AND AIM: Gadolinium‐ethoxybenzyl‐diethylenetriamine pentaacetic acid (Gd‐EOB‐DTPA)‐enhanced magnetic resonance imaging (EOB‐MRI) has been recognized as a useful imaging technique to distinguish the biological behavior of hepatocellular carcinoma (HCC). METHODS: We analyzed 217 hepatectomy recipients with HCCs measuring 10 cm or less. We divided the patients into a decreased intensity (DI) group (n = 189, 87%) and an increased or neutral intensity (INI) group (n = 28, 13%) according to the ratio of tumor intensity to liver intensity during the hepatobiliary phase (HBP). According to the ratio of the maximum tumor diameter (including peritumoral hypointensity) between HBP images and precontrast T1‐weighted images (RHBPP), we divided the patients as follows: The group whose RHBPP was ≥1.036 was the high RHBPP group (n = 60, 28%), and the group whose RHBPP was <1.036 was the low RHBPP group (n = 157, 72%). We investigated the prognoses and clinicopathological characteristics of these patients. RESULTS: DI versus INI was not a prognostic factor for either survival or recurrence; however, a high RHBPP was an independent predictor of unfavorable survival and recurrence in patients. In addition, the INI group showed significantly lower α‐fetoprotein (AFP) levels and higher rates of well‐differentiated HCC and ICGR15 ≥15% than the DI group. The high RHBPP group showed significantly higher rates of vascular invasion and poorly differentiated HCC than the low RHBPP group. CONCLUSIONS: A high RHBPP by EOB‐MRI is a preoperative predictor of vascular invasion and an unfavorable prognostic factor for survival and recurrence. These patients might be considered for highly curative operations such as anatomical liver resection. |
format | Online Article Text |
id | pubmed-7812518 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Wiley Publishing Asia Pty Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-78125182021-01-22 Impact of gadolinium‐ethoxybenzyl‐diethylenetriamine pentaacetic acid‐enhanced magnetic resonance imaging on the prognosis of hepatocellular carcinoma after surgery Shimada, Shingo Kamiyama, Toshiya Kakisaka, Tatsuhiko Orimo, Tatsuya Nagatsu, Akihisa Asahi, Yoh Sakamoto, Yuzuru Abo, Daisuke Kamachi, Hirofumi Taketomi, Akinobu JGH Open Original Articles BACKGROUND AND AIM: Gadolinium‐ethoxybenzyl‐diethylenetriamine pentaacetic acid (Gd‐EOB‐DTPA)‐enhanced magnetic resonance imaging (EOB‐MRI) has been recognized as a useful imaging technique to distinguish the biological behavior of hepatocellular carcinoma (HCC). METHODS: We analyzed 217 hepatectomy recipients with HCCs measuring 10 cm or less. We divided the patients into a decreased intensity (DI) group (n = 189, 87%) and an increased or neutral intensity (INI) group (n = 28, 13%) according to the ratio of tumor intensity to liver intensity during the hepatobiliary phase (HBP). According to the ratio of the maximum tumor diameter (including peritumoral hypointensity) between HBP images and precontrast T1‐weighted images (RHBPP), we divided the patients as follows: The group whose RHBPP was ≥1.036 was the high RHBPP group (n = 60, 28%), and the group whose RHBPP was <1.036 was the low RHBPP group (n = 157, 72%). We investigated the prognoses and clinicopathological characteristics of these patients. RESULTS: DI versus INI was not a prognostic factor for either survival or recurrence; however, a high RHBPP was an independent predictor of unfavorable survival and recurrence in patients. In addition, the INI group showed significantly lower α‐fetoprotein (AFP) levels and higher rates of well‐differentiated HCC and ICGR15 ≥15% than the DI group. The high RHBPP group showed significantly higher rates of vascular invasion and poorly differentiated HCC than the low RHBPP group. CONCLUSIONS: A high RHBPP by EOB‐MRI is a preoperative predictor of vascular invasion and an unfavorable prognostic factor for survival and recurrence. These patients might be considered for highly curative operations such as anatomical liver resection. Wiley Publishing Asia Pty Ltd 2020-10-30 /pmc/articles/PMC7812518/ /pubmed/33490612 http://dx.doi.org/10.1002/jgh3.12444 Text en © 2020 The Authors. JGH Open published by Journal of Gastroenterology and Hepatology Foundation and John Wiley & Sons Australia, Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Articles Shimada, Shingo Kamiyama, Toshiya Kakisaka, Tatsuhiko Orimo, Tatsuya Nagatsu, Akihisa Asahi, Yoh Sakamoto, Yuzuru Abo, Daisuke Kamachi, Hirofumi Taketomi, Akinobu Impact of gadolinium‐ethoxybenzyl‐diethylenetriamine pentaacetic acid‐enhanced magnetic resonance imaging on the prognosis of hepatocellular carcinoma after surgery |
title | Impact of gadolinium‐ethoxybenzyl‐diethylenetriamine pentaacetic acid‐enhanced magnetic resonance imaging on the prognosis of hepatocellular carcinoma after surgery |
title_full | Impact of gadolinium‐ethoxybenzyl‐diethylenetriamine pentaacetic acid‐enhanced magnetic resonance imaging on the prognosis of hepatocellular carcinoma after surgery |
title_fullStr | Impact of gadolinium‐ethoxybenzyl‐diethylenetriamine pentaacetic acid‐enhanced magnetic resonance imaging on the prognosis of hepatocellular carcinoma after surgery |
title_full_unstemmed | Impact of gadolinium‐ethoxybenzyl‐diethylenetriamine pentaacetic acid‐enhanced magnetic resonance imaging on the prognosis of hepatocellular carcinoma after surgery |
title_short | Impact of gadolinium‐ethoxybenzyl‐diethylenetriamine pentaacetic acid‐enhanced magnetic resonance imaging on the prognosis of hepatocellular carcinoma after surgery |
title_sort | impact of gadolinium‐ethoxybenzyl‐diethylenetriamine pentaacetic acid‐enhanced magnetic resonance imaging on the prognosis of hepatocellular carcinoma after surgery |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7812518/ https://www.ncbi.nlm.nih.gov/pubmed/33490612 http://dx.doi.org/10.1002/jgh3.12444 |
work_keys_str_mv | AT shimadashingo impactofgadoliniumethoxybenzyldiethylenetriaminepentaaceticacidenhancedmagneticresonanceimagingontheprognosisofhepatocellularcarcinomaaftersurgery AT kamiyamatoshiya impactofgadoliniumethoxybenzyldiethylenetriaminepentaaceticacidenhancedmagneticresonanceimagingontheprognosisofhepatocellularcarcinomaaftersurgery AT kakisakatatsuhiko impactofgadoliniumethoxybenzyldiethylenetriaminepentaaceticacidenhancedmagneticresonanceimagingontheprognosisofhepatocellularcarcinomaaftersurgery AT orimotatsuya impactofgadoliniumethoxybenzyldiethylenetriaminepentaaceticacidenhancedmagneticresonanceimagingontheprognosisofhepatocellularcarcinomaaftersurgery AT nagatsuakihisa impactofgadoliniumethoxybenzyldiethylenetriaminepentaaceticacidenhancedmagneticresonanceimagingontheprognosisofhepatocellularcarcinomaaftersurgery AT asahiyoh impactofgadoliniumethoxybenzyldiethylenetriaminepentaaceticacidenhancedmagneticresonanceimagingontheprognosisofhepatocellularcarcinomaaftersurgery AT sakamotoyuzuru impactofgadoliniumethoxybenzyldiethylenetriaminepentaaceticacidenhancedmagneticresonanceimagingontheprognosisofhepatocellularcarcinomaaftersurgery AT abodaisuke impactofgadoliniumethoxybenzyldiethylenetriaminepentaaceticacidenhancedmagneticresonanceimagingontheprognosisofhepatocellularcarcinomaaftersurgery AT kamachihirofumi impactofgadoliniumethoxybenzyldiethylenetriaminepentaaceticacidenhancedmagneticresonanceimagingontheprognosisofhepatocellularcarcinomaaftersurgery AT taketomiakinobu impactofgadoliniumethoxybenzyldiethylenetriaminepentaaceticacidenhancedmagneticresonanceimagingontheprognosisofhepatocellularcarcinomaaftersurgery |